BrightGene Bio-Medical Technology Co., Ltd. Share Price
Equities
688166
CNE100003PR1
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.37 CNY | -1.08% |
|
-9.03% | +27.13% |
| 05-12 | Brightgene Bio-Medical Reports Phase Iii Results for Bgm0504 | CI |
| 05-06 | Participants of BrightGene's Phase 3 Trial See Trimmed Waistlines | MT |
| Capitalization | 26.35B 3.87B 3.33B 3.04B 2.9B 5.32B 371B 5.41B 36.56B 14.12B 176B 14.52B 14.21B 614B | P/E ratio 2024 |
67.1x | P/E ratio 2025 | 377x |
|---|---|---|---|---|---|
| Enterprise value | 27.79B 4.08B 3.51B 3.21B 3.06B 5.61B 392B 5.71B 38.55B 14.89B 186B 15.31B 14.99B 648B | EV / Sales 2024 |
11.1x | EV / Sales 2025 | 18.1x |
| Free-Float |
58.99% | Yield 2024 |
0.32% | Yield 2025 | 0.03% |
| 1 day | -1.08% | ||
| 1 week | -9.03% | ||
| Current month | -1.16% | ||
| 1 month | +29.80% | ||
| 3 months | +37.56% | ||
| 6 months | +13.71% | ||
| Current year | +27.13% |
| 1 week | 60.41 |  | 67.47 |
| 1 month | 55.66 | | 72.88 |
| Current year | 38.89 | | 72.88 |
| 1 year | 38.89 | | 122.59 |
| 3 years | 17.81 | | 122.59 |
| 5 years | 17.1 | | 122.59 |
| 10 years | 17.1 | | 122.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Dong Yuan
CEO | Chief Executive Officer | 56 | 25/10/2001 |
Yuan Lai Zou
DFI | Director of Finance/CFO | 55 | 31/12/2010 |
Nan Ding
IRC | Investor Relations Contact | 35 | 19/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Jian Dong Yuan
CHM | Chairman | 56 | 25/10/2001 |
Kai Li
BRD | Director/Board Member | 50 | 28/02/2011 |
Lei Su
BRD | Director/Board Member | 38 | 30/04/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.08% | -9.03% | +25.34% | +196.01% | 3.93B | |
| -0.00% | +3.07% | +40.44% | +131.32% | 898B | |
| -1.77% | +1.89% | +54.90% | +41.01% | 556B | |
| -0.18% | +3.79% | +18.57% | +42.98% | 372B | |
| +0.88% | +1.41% | +26.84% | +13.36% | 326B | |
| -0.79% | +2.39% | +36.02% | +13.51% | 287B | |
| -0.10% | +2.98% | +30.60% | +26.10% | 285B | |
| -1.79% | -0.82% | +51.60% | -4.92% | 280B | |
| +0.91% | +1.25% | -30.88% | -49.10% | 207B | |
| -2.22% | -0.84% | +24.41% | +40.08% | 181B | |
| Average | +0.02% | +1.78% | +27.78% | +45.03% | 339.63B | |
| Weighted average by Cap. | +0.15% | +2.63% | +33.60% | +49.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.28B 188M 162M 148M 141M 259M 18.07B 264M 1.78B 687M 8.57B 707M 692M 29.9B | 1.22B 180M 155M 141M 135M 247M 17.24B 251M 1.7B 656M 8.18B 674M 660M 28.52B |
| Net income | 189M 27.78M 23.89M 21.84M 20.84M 38.17M 2.67B 38.87M 262M 101M 1.26B 104M 102M 4.41B | 54.51M 8.01M 6.88M 6.29M 6.01M 11M 768M 11.2M 75.62M 29.21M 364M 30.04M 29.4M 1.27B |
| Net Debt | 1.47B 216M 186M 170M 162M 297M 20.72B 302M 2.04B 788M 9.82B 810M 793M 34.28B | 1.43B 211M 181M 165M 158M 289M 20.2B 295M 1.99B 768M 9.58B 790M 773M 33.42B |
Employees
1,196
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/05/26 | 62.37 ¥ | -1.08% | 12,352,920 |
| 14/05/26 | 63.05 ¥ | -4.97% | 13,090,890 |
| 13/05/26 | 66.35 ¥ | +1.92% | 10,000,760 |
| 12/05/26 | 65.10 ¥ | +0.35% | 14,204,860 |
| 11/05/26 | 64.87 ¥ | -2.66% | 14,959,070 |
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688166 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition